CIK 0001783328 · <br>Emerging growth company
TScan Therapeutics, Inc.
Sign in to watch- Ticker
- TCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 825282075
- Phone
- 857-399-9500
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SC 13G Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Results of operations · Other events
- FWP Offering Free Writing Prospectus
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure · Other events
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-K/A Report 10-K/A
- 8-K Event Other events
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
Page 7 of 17 · 336 filings